Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins

Shmuel Bentov; Amir Sagi; Amir Berman; Assaf Shechter

Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins

Shmuel Bentov (Inventor), Amir Sagi (Inventor), Amir Berman (Inventor), Assaf Shechter (Inventor)

Research output: Patent

Abstract

Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid or phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12. The compositions are useful in pharmaceutical and nutraceutical formulations.

Original language	English
Patent number	CN101969962
IPC	C07K 14/ 435 A I
Priority date	22/10/08
State	Published - 9 Feb 2011

Cite this

@misc{93666ca0f2b24a62ae21150435658c60,

title = "Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins",

abstract = "Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid or phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12. The compositions are useful in pharmaceutical and nutraceutical formulations.",

author = "Shmuel Bentov and Amir Sagi and Amir Berman and Assaf Shechter",

year = "2011",

month = feb,

day = "9",

language = "English",

type = "Patent",

note = "CN101969962; C07K 14/ 435 A I",

}

TY - PAT

T1 - Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins

AU - Bentov, Shmuel

AU - Sagi, Amir

AU - Berman, Amir

AU - Shechter, Assaf

PY - 2011/2/9

Y1 - 2011/2/9

N2 - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid or phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12. The compositions are useful in pharmaceutical and nutraceutical formulations.

AB - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid or phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12. The compositions are useful in pharmaceutical and nutraceutical formulations.

M3 - Patent

M1 - CN101969962

ER -

Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins

Abstract

Fingerprint

Cite this